Uric Acid as a Marker of Mortality and Morbidity in Fabry Disease

Open Access

Peer-reviewed

Research Article

Daniel Rob,

Affiliation 2nd Department of Medicine - Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
⨯
Josef Marek,

Affiliation 2nd Department of Medicine - Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
⨯
Gabriela Dostálová,

Affiliation 2nd Department of Medicine - Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
⨯
Lubor Goláň,

Affiliation 2nd Department of Medicine - Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
⨯
Aleš Linhart

* E-mail: alinh@lf1.cuni.cz

Affiliation 2nd Department of Medicine - Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
⨯

Reader Comments (0)

Oxidative stress
Is the Subject Area "Oxidative stress" applicable to this article?

Thanks for your feedback.
Glomerular filtration rate
Is the Subject Area "Glomerular filtration rate" applicable to this article?

Thanks for your feedback.
Cardiovascular disease risk
Is the Subject Area "Cardiovascular disease risk" applicable to this article?

Thanks for your feedback.
Enzyme replacement therapy
Is the Subject Area "Enzyme replacement therapy" applicable to this article?

Thanks for your feedback.
Morbidity
Is the Subject Area "Morbidity" applicable to this article?

Thanks for your feedback.
Uric acid
Is the Subject Area "Uric acid" applicable to this article?

Thanks for your feedback.
Cardiac hypertrophy
Is the Subject Area "Cardiac hypertrophy" applicable to this article?

Thanks for your feedback.
Metabolic disorders
Is the Subject Area "Metabolic disorders" applicable to this article?

Thanks for your feedback.